A Phase 1 Study of Liposome Encapsulated Docetaxel (LE-DT) in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 25 Jun 2014
At a glance
- Drugs Docetaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 25 Jun 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 18 Nov 2009 Results have been presented at the joint AACR-NCI-EORTC conference, according to a NeoPharm media release.
- 29 Apr 2009 Patient enrolment is continuing and trial completion in planned for the second quarter of 2009, as reported in a NeoPharm media release.